Second Revision of USP Chapter <1> Injections and Implanted Drug Products (Parenterals)-Product Quality Tests
Recommendation
25/26 November 2025
Nitrogen, Compressed Air, Pure Steam
Register now for ECA's GMP Newsletter
Last year already, the revision of the General Chapter on quality testing of sterile medicinal products was initiated in the USP 38 NF 33. The targeted official date for coming into force was the 1st May 2016. Now, the USP has announced that because of some comments received, there will be a further revision. This is due to the USP's intention to support in Chapter 1 both existing monographs as well as new monographs to be developed. The new scope should now be focussed again to avoid confusion. The publication is striven for March 2016 as well as the adoption of the changes in the USP 40 NF 35. Furthermore, USP has announced that also the contents of General Chapters <2> to <5> will be examined.
On the USP website you will find further details regarding the revision of Chapter <1>.
Related GMP News
05.11.2025ECA revises Container-/Closure-Integrity Testing (CCIT) Position Paper
05.11.2025Ozone Concentration during the Sanitization of PW and WFI Systems
29.10.2025Is Surface Roughness in Pure Steam Systems relevant to GMP?
01.10.2025Different Sanitation Strategies for Sections of a WFI Systems?
24.09.2025Warning Letter due to Particles in Infusion Bags
24.09.2025New USP Chapter on oral Dosage Forms